Post Profile






Study Finds Ruxolitinib Effective in Reducing Symptoms for Myelofibrosis Patients

For patients diagnosed with myelofibrosis, a bone marrow disorder that disrupts the body’s normal production of blood cells, new hope may be on the horizon. A study, published in the March 1 edition of the New England Journal of Medicine, … Continue reading ?
read more

share

Related Posts


Symptoms Of Myelofibrosis Relieved By Ruxolitinib

Health : Medical News Today

People with a blood cancer - myelofibrosis - can benefit from a drug called ruxolitinib, according to a randomized, double-blind, placebo-controlled clinical trial that included patients and researchers from the Stanford University ...

Ruxolitinib Produces Durable Improvements In Patients With Myelofibrosis

Health : Medical News Today

ATLANTA - Ruxolitinib reduces splenomegaly and other symptoms commonly associated with myelofibrosis, and the results are maintained for at least two years, according to results released at the 54th American Society of Hematology An...

Drug Improves Survival and Quality of Life for People with Myelofibrosis

Health : Newswise Medical News

A drug that relieves the severe symptoms of a life-threatening bone marrow cancer called myelofibrosis also improves the survival of patients with the disease, according to a phase III clinical trial published in the March 1 edition...

Finding a Universal Language to Connect Patients With Bone Marrow Donors

Society & Culture : Huffington Post: Impact Blog

Bill Erickson owes his life to an altruistic stranger in Germany -- and the algorithm that helped find him. Erickson, an Illinois resident, was diagnosed myelofibrosis -- a serious bone marrow disorder that disrupts the body's blood...

Jakafi (ruxolitinib) Approved For Bone Marrow Disease Myelofibrosis, US FDA

Health : Medical News Today

Jakafi (ruxolitinib) has been approved by the FDA (Food and Drug Administration) for the treatment of myelofibrosis, a serious bone marrow disease that disrupts the body's normal production of blood cells. The FDA says this is the f...

Comments


Copyright © 2016 Regator, LLC